Somma-Mauvais H, Soulayrol S, Duvocelle A, Azulay J-P, Gastaut J-L
Pôle neurosciences cliniques, neurophysiologie clinique, hôpital Nord, chemin des Bourrelly, Marseille cedex 20, France.
Rev Neurol (Paris). 2010 Jun-Jul;166(6-7):630-8. doi: 10.1016/j.neurol.2009.12.008. Epub 2010 Feb 26.
Writer's cramp is a focal dystonia; treatment remains disappointing. We report our 14-year experience with a population of 119 patients aged between 18 and 85 years (average age 43 years).
Treatment was based on botulinum toxin injections (Dysport) and physiotherapy. Patients were reviewed every four to six months with clinical and video evaluation by three different observers and subjective analysis of the treatment efficiency by the patient (score of 1 to 3). The post-injection deficit, if present, was also quantified.
In the group treated with toxin and physiotherapy, cramps improved (score 2 and 3) in 61.6% of patients; a majority of patients (n=14) reported they were moderately satisfied (score 2). In the group treated with toxin alone, 37.9% of patients were improved (score 2 and 3) with a majority (n=18) very satisfied reporting normal writing (score 3). Age was not a predictor of therapeutic response. Good results were obtained with injections of the flexor carpi radialis followed by flexor digitorum profundus II and III and the flexor pollicis longus. Seventy-one per cent of injections caused moderate muscle weakness, minimally disabling compared to the benefit of injections. Twenty-seven patients were followed for more than two years and three patients, who had achieved score 3 with excellent response, were followed for 14 years with very efficient repeated injections. If the injections were not effective the first time, we re-assessed the situation and adjusted the injections; we considered that toxin treatment was unsuccessful after three injections without benefit.
The choice treatment for writer's cramp remains well-targeted injections of botulinum toxin. Physiotherapy is useful when the toxin injections are ineffective in completely improving writing. This requires close cooperation between the injector, the physiotherapist and the patient.
书写痉挛是一种局限性肌张力障碍;治疗效果仍然令人失望。我们报告了对119例年龄在18至85岁(平均年龄43岁)患者的14年治疗经验。
治疗基于肉毒毒素注射(Dysport)和物理治疗。每四至六个月对患者进行复查,由三名不同的观察者进行临床和视频评估,并由患者对治疗效果进行主观分析(评分1至3分)。如有注射后功能缺损,也进行量化。
在接受毒素和物理治疗的组中,61.6%的患者痉挛症状改善(评分2分和3分);大多数患者(n = 14)表示中度满意(评分2分)。在仅接受毒素治疗的组中,37.9%的患者症状改善(评分2分和3分),大多数(n = 18)表示非常满意,称书写功能正常(评分3分)。年龄不是治疗反应的预测因素。注射桡侧腕屈肌,随后注射指深屈肌Ⅱ和Ⅲ以及拇长屈肌,取得了良好效果。71%的注射导致中度肌肉无力,与注射带来的益处相比,致残程度极低。27例患者随访超过两年,3例最初获得3分且反应极佳的患者随访了14年,重复注射效果良好。如果首次注射无效,我们会重新评估情况并调整注射方案;如果三次注射均无益处,我们认为毒素治疗失败。
书写痉挛的首选治疗方法仍然是针对性良好的肉毒毒素注射。当毒素注射不能完全改善书写功能时,物理治疗是有用的。这需要注射医生、物理治疗师和患者之间密切合作。